American Century Companies Inc Ocuphire Pharma, Inc. Transaction History

American Century Companies Inc

  • $167 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 14, 2024
BUY
$1.89 - $3.27 $10,686 - $18,488
5,654 Added 9.38%
65,911 $132,000
Q4 2023

Feb 13, 2024
BUY
$2.59 - $3.64 $156,065 - $219,335
60,257 New
60,257 $181,000
Q3 2023

Nov 13, 2023
BUY
$3.35 - $4.33 $108,081 - $139,698
32,263 Added 114.86%
60,353 $202,000
Q2 2023

Aug 14, 2023
BUY
$3.63 - $6.38 $101,966 - $179,214
28,090 New
28,090 $121,000

Others Institutions Holding OCUP

# of Institutions
43
Shares Held
2.58M
Call Options Held
14.1K
Put Options Held
800
View Full List

About Ocuphire Pharma, Inc.

OCUP Quotes by TradingView
  • Ticker OCUP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 20,579,800
  • Market Cap $20.2M
  • Description
  • Ocuphire Pharma, Inc., a clinical-stage ophthalmic biopharmaceutical company, focuses on developing and commercializing therapies for the treatment of refractive and retinal eye disorders. Its lead product candidate is Nyxol eye drops, a once-daily preservative-free eye drop formulation of phentolamine mesylate, which is in Phase III clinical tr...
More about OCUP
Track This Portfolio

Track American Century Companies Inc Portfolio

Follow American Century Companies Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of American Century Companies Inc, based on Form 13F filings with the SEC.

News

Stay updated on American Century Companies Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email